Genitourinary Cancer

Top Story

Assessment tool may identify older patients at risk for chemotherapy toxicity

Assessment tool may identify older patients at risk for chemotherapy toxicity
May 27, 2016

An assessment tool comprised of clinically relevant questions and specific treatment information accurately predicted risk for chemotherapy toxicity in a majority of older patients with cancer, according to the results of a validation study.

Older adults face an increased risk for chemotherapy toxicity during cancer treatment; as such, they are less likely to be offered chemotherapy than their younger counterparts.

In the Journals

Male cancer survivors less likely to have children

May 25, 2016
Male survivors of childhood cancer diagnosed before age 25 years appeared less likely to have children and more likely to require assisted reproduction than men who did…
Cover Story

Value in cancer care must ‘start with patients, not dollars’

HemOnc Today, May 25, 2016
The skyrocketing cost of cancer care has come under intense criticism from patients and health care providers.Several promising treatments — including traditional…
In the Journals

Tumor biology may explain racial disparities in clear cell RCC survival

HemOnc Today, May 25, 2016
Distinct differences in tumor biology may explain racial disparities in survival of patients with clear cell renal cell carcinoma, according to study results.Studies…
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video

MET targeting, PD-L1/PD-1 inhibition highlight recent developments in genitourinary oncology

February 11, 2015
More »
Featured
AACR Annual Meeting

AACR Annual Meeting

CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
In the Journals

Assessment tool may identify older patients at risk for chemotherapy toxicity

May 27, 2016
An assessment tool comprised of clinically relevant questions and specific treatment information accurately predicted risk for chemotherapy toxicity…

In the Journals

Male cancer survivors less likely to have children

May 25, 2016
Male survivors of childhood cancer diagnosed before age 25 years appeared less likely to have children and more likely to require assisted…

Cover Story

Value in cancer care must ‘start with patients, not dollars’

HemOnc Today, May 25, 2016
The skyrocketing cost of cancer care has come under intense criticism from patients and health care providers.Several promising treatments —…

In the Journals

Tumor biology may explain racial disparities in clear cell RCC survival

HemOnc Today, May 25, 2016
Distinct differences in tumor biology may explain racial disparities in survival of patients with clear cell renal cell carcinoma, according to study…

In the Journals

Geriatric events increase morbidity, costs among older patients who undergo cancer surgery

May 24, 2016
Older individuals who underwent cancer surgery appeared likely to experience geriatric events, such as falls and fractures, delirium and…

‘Surge’ in unnecessary CT scans significantly increases cancer risks

May 23, 2016
A single standard CT scan may increase the risk for fatal cancer in one of every 2,000 patients, according to FDA data.Repeat or excessive exposure…

In the JournalsPerspective

Lifestyle changes can reduce cancer incidence, mortality

May 20, 2016
The adoption of healthy lifestyle practices may prevent a large proportion of cancers and reduce cancer mortality in the United States, according to…

Meeting News CoveragePerspective

Precision medicine approach improves outcomes in phase 1 trials

May 19, 2016
Patients treated in phase 1 trials designed with a biomarker-based approach for treatment selection demonstrated higher response rates and longer…

FDA News

FDA approves Tecentriq, first anti–PD-L1 immunotherapy to treat bladder cancer

May 18, 2016
The FDA granted accelerated approval to atezolizumab for the treatment of locally advanced or metastatic urothelial carcinoma.Atezolizumab…

Congressional subcommittee debates Medicare Part B demonstration project

May 17, 2016
The U.S. House Energy Subcommittee on Health today held a hearing to offer doctor and patient perspectives on planned changes to the Medicare Part B…

More Headlines »
morganatic-roan
morganatic-roan